These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2439230)

  • 1. Evidence for distinct calcium channel agonist and antagonist binding sites in intact cultured embryonic chick ventricular cells.
    Lee RT; Smith TW; Marsh JD
    Circ Res; 1987 May; 60(5):683-91. PubMed ID: 2439230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
    Greenberg DA; Carpenter CL; Messing RO
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
    Rampe D; Poder T; Zhao ZY; Schilling WP
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P
    J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
    Zheng W; Hawthorn M; Triggle DJ
    Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental regulation of cardiac calcium channels and contractile sensitivity to [Ca]o.
    Marsh JD; Allen PD
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H179-85. PubMed ID: 2463772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
    Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
    Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes.
    Kanaya N; Matsumoto M; Kawana S; Tsuchida H; Kimura H; Miyamoto A; Ohshika H; Namiki A
    Can J Anaesth; 1998 Jun; 45(6):584-91. PubMed ID: 9669017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple calcium channels in synaptosomes: voltage dependence of 1,4-dihydropyridine binding and effects on function.
    Dunn SM
    Biochemistry; 1988 Jul; 27(14):5275-81. PubMed ID: 2458759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antagonism of calcium channel activators by fluspirilene.
    Kenny BA; Fraser S; Kilpatrick AT; Spedding M
    Br J Pharmacol; 1990 Jun; 100(2):211-6. PubMed ID: 1696149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK; Bolger GT
    Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional dihydropyridine binding site associated with slow calcium channel in rat cultured neurones.
    Maloteaux JM; Octave JN; Laterre EC
    Neurosci Lett; 1988 Apr; 87(1-2):168-72. PubMed ID: 2454427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the negative inotropic effects of 17 beta-oestradiol in human isolated myocardial tissues.
    Sitzler G; Lenz O; Kilter H; La Rosee K; Böhm M
    Br J Pharmacol; 1996 Sep; 119(1):43-8. PubMed ID: 8872355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic and calcium kinetic effects of calcium channel agonist and antagonist in isolated cardiac myocytes from cardiomyopathic hamsters.
    Sen LY; O'Neill M; Marsh JD; Smith TW
    Circ Res; 1990 Sep; 67(3):599-608. PubMed ID: 1697792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-PN200-110 and ouabain binding sites in purified bovine adrenomedullary plasma membranes and chromaffin cells.
    Castillo CJ; Fonteríz RI; López MG; Rosenheck K; García AG
    J Neurochem; 1989 Nov; 53(5):1442-9. PubMed ID: 2529351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.